AGC
TNDM icon

Alden Global Capital’s Tandem Diabetes Care TNDM Stock Holding History

Alden Global Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-7,570
Closed -$955K – 22
2015
Q1 		$955K Buy
+7,570
New +$984K 0.68% 18

Other funds holding TNDM

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Alden Global Capital's TNDM Position: Q2 2015 in Review

Alden Global Capital sold out of Tandem Diabetes Care (TNDM) in Q2 2015, closing a stake of 7,570 shares — an estimated $955K sold.

Alden Global Capital first reported a position in TNDM in Q1 2015 and held it in 1 quarter. The position peaked at $955K in Q1 2015. 87 funds tracked by Wall St. Rank hold TNDM as of Q2 2015.

  • Alden Global Capital reported no remaining Tandem Diabetes Care position as of Q2 2015 after selling out during the quarter.
  • Alden Global Capital sold 7,570 Tandem Diabetes Care shares in Q2 2015, an estimated $955K.
  • Alden Global Capital first reported a position in Tandem Diabetes Care in Q1 2015 and held it in 1 quarter.
  • Alden Global Capital's Tandem Diabetes Care position peaked at $955K in Q1 2015.
  • 87 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2015.

Based on Alden Global Capital's 13F filing for Q2 2015, filed 14 Aug 2015.